METAGENOMI THERAPEUTICS INC
MGX·59102M104·US·Common Stock·Healthcare - Biotechnology
MGX (METAGENOMI THERAPEUTICS INC) is held by 34 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.4M), RENAISSANCE TECHNOLOGIES LLC ($1.1M), TWO SIGMA INVESTMENTS, LP ($665,668). Net institutional sentiment: Mixed.
34
Holders
Avg rating(8 Elite)
$6M
Total Value
40% (40)
Fund Consensus
12 buying - 18 selling
Who's Trading
InsiderIJIrish JianSell $5KJun 5, 2026
InsiderWPWapnick PamelaSell $4KJun 5, 2026
InsiderWMWein MatthewSell $724.84Jun 5, 2026
InsiderIJIrish JianSell $3KMar 5, 2026
InsiderWPWapnick PamelaSell $3KMar 5, 2026
InsiderWMWein MatthewSell $771.2Mar 5, 2026
InsiderTCThomas Brian C.Sell $7KDec 5, 2025
InsiderIJIrish JianSell $3KDec 5, 2025
InsiderWPWapnick PamelaSell $3KDec 5, 2025
InsiderWMWein MatthewSell $352.61Dec 5, 2025
13F: Insider & Congress:
Showing 1-20 of 40
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer